Lars H. Jensen

831 total citations
25 papers, 721 citations indexed

About

Lars H. Jensen is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Lars H. Jensen has authored 25 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 5 papers in Toxicology. Recurrent topics in Lars H. Jensen's work include Cancer therapeutics and mechanisms (23 papers), Lung Cancer Research Studies (10 papers) and Neutropenia and Cancer Infections (9 papers). Lars H. Jensen is often cited by papers focused on Cancer therapeutics and mechanisms (23 papers), Lung Cancer Research Studies (10 papers) and Neutropenia and Cancer Infections (9 papers). Lars H. Jensen collaborates with scholars based in Denmark, United States and Singapore. Lars H. Jensen's co-authors include Maxwell Sehested, Peter Buhl Jensen, John L. Nitiss, Morten Grauslund, Irene Wessel, Rune Matthiesen, Ole N. Jensen, Hans Christian Beck, Anne Maria Kaldal Hansen and Paul W. Finn and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

In The Last Decade

Lars H. Jensen

25 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars H. Jensen Denmark 16 600 240 105 87 86 25 721
Elizabeth Altschuler United States 11 331 0.6× 147 0.6× 60 0.6× 81 0.9× 13 0.2× 17 391
Krzysztof Staroń Poland 14 399 0.7× 113 0.5× 41 0.4× 51 0.6× 3 0.0× 50 490
Marek Šarišský Slovakia 15 245 0.4× 49 0.2× 40 0.4× 129 1.5× 7 0.1× 25 530
Mithu Banerjee India 4 283 0.5× 74 0.3× 34 0.3× 237 2.7× 30 0.3× 4 503
Lulu Li China 14 382 0.6× 73 0.3× 17 0.2× 57 0.7× 11 0.1× 22 565
Prakash B. Palde United States 12 454 0.8× 65 0.3× 9 0.1× 299 3.4× 20 0.2× 16 724
Rosalba Florio Italy 16 329 0.5× 102 0.4× 13 0.1× 116 1.3× 11 0.1× 26 530
Ikuo Mitsui Japan 11 311 0.5× 231 1.0× 59 0.6× 189 2.2× 3 0.0× 17 517
Sai-Peng Sim Malaysia 5 351 0.6× 149 0.6× 41 0.4× 52 0.6× 4 0.0× 10 461
Iwao Kitamura Japan 8 266 0.4× 131 0.5× 61 0.6× 188 2.2× 55 0.6× 13 483

Countries citing papers authored by Lars H. Jensen

Since Specialization
Citations

This map shows the geographic impact of Lars H. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars H. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars H. Jensen more than expected).

Fields of papers citing papers by Lars H. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars H. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars H. Jensen. The network helps show where Lars H. Jensen may publish in the future.

Co-authorship network of co-authors of Lars H. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars H. Jensen. A scholar is included among the top collaborators of Lars H. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars H. Jensen. Lars H. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Elke, Annemette Thougaard, Morten Grauslund, et al.. (2008). Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy. Toxicology. 255(1-2). 72–79. 76 indexed citations
2.
Grauslund, Morten, Annemette Thougaard, Annette Füchtbauer, et al.. (2007). A Mouse Model for Studying the Interaction of Bisdioxopiperazines with Topoisomerase IIα in Vivo. Molecular Pharmacology. 72(4). 1003–1014. 17 indexed citations
3.
Jensen, Lars H., Peter Bjødstrup Jensen, Robert H. Shoemaker, & Maxwell Sehested. (2006). SAR analysis of substituted purines as topoisomerase II inhibitors identifies ATPase inhibitors with nanomolar activity.. Cancer Research. 66. 1301–1301. 2 indexed citations
4.
Beck, Hans Christian, Rune Matthiesen, Lars H. Jensen, et al.. (2006). Quantitative Proteomic Analysis of Post-translational Modifications of Human Histones. Molecular & Cellular Proteomics. 5(7). 1314–1325. 164 indexed citations
5.
6.
Grauslund, Morten, et al.. (2005). Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase II. Biochemical and Biophysical Research Communications. 334(3). 853–860. 2 indexed citations
7.
Huang, Sheng‐Li, Irene Wessel, Lars H. Jensen, et al.. (2005). Stability of the Topoisomerase II Closed Clamp Conformation May Influence DNA-stimulated ATP Hydrolysis. Journal of Biological Chemistry. 280(12). 11920–11929. 21 indexed citations
8.
Hofland, Kenneth Francis, Annemette Thougaard, Lars H. Jensen, et al.. (2005). Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors. Clinical Cancer Research. 11(18). 6722–6729. 18 indexed citations
9.
10.
Walker, Jerrylaine V., Karin C. Nitiss, Lars H. Jensen, et al.. (2004). A Mutation in Human Topoisomerase II α Whose Expression Is Lethal in DNA Repair-deficient Yeast Cells. Journal of Biological Chemistry. 279(25). 25947–25954. 16 indexed citations
11.
Renodon‐Cornière, Axelle, et al.. (2003). Probing the Role of Linker Substituents in Bisdioxopiperazine Analogs for Activity against Wild-Type and Mutant Human Topoisomerase IIα. Molecular Pharmacology. 63(5). 1159–1168. 4 indexed citations
12.
Jensen, Lars H., Axelle Renodon‐Cornière, Karin C. Nitiss, et al.. (2003). A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II α. Biochemical Pharmacology. 66(4). 623–631. 10 indexed citations
13.
Renodon‐Cornière, Axelle, Lars H. Jensen, John L. Nitiss, Peter Buhl Jensen, & Maxwell Sehested. (2003). Analysis of Bisdioxopiperazine Dexrazoxane Binding to Human DNA Topoisomerase II α:  Decreased Binding as a Mechanism of Drug Resistance. Biochemistry. 42(32). 9749–9754. 8 indexed citations
14.
Wessel, Irene, Lars H. Jensen, Axelle Renodon‐Cornière, et al.. (2002). Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF‐187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase IIα. FEBS Letters. 520(1-3). 161–166. 21 indexed citations
15.
Renodon‐Cornière, Axelle, Lars H. Jensen, John L. Nitiss, Peter Buhl Jensen, & Maxwell Sehested. (2002). Interaction of Human DNA Topoisomerase II α with DNA:  Quantification by Surface Plasmon Resonance. Biochemistry. 41(45). 13395–13402. 18 indexed citations
16.
Jensen, Lars H., Karin C. Nitiss, Junfang Zhou, et al.. (2000). A Novel Mechanism of Cell Killing by Anti-topoisomerase II Bisdioxopiperazines. Journal of Biological Chemistry. 275(3). 2137–2146. 87 indexed citations
17.
Jensen, Lars H., et al.. (2000). N‐terminal and core‐domain random mutations in human topoisomerase II α conferring bisdioxopiperazine resistance. FEBS Letters. 480(2-3). 201–207. 19 indexed citations
18.
Wessel, Irene, Lars H. Jensen, John L. Nitiss, Jensen Pb, & Maxwell Sehested. (2000). Four out of six human NYH small cell lung cancer cell lines resistant to ICRF-187 have either R162Q or Y165S functional mutations in the Walker ATP binding site of topoisomerase II alpha. Lung Cancer. 29(1). 11–11. 1 indexed citations
19.
Sehested, Maxwell, Irene Wessel, Lars H. Jensen, et al.. (1998). Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.. PubMed. 58(7). 1460–8. 53 indexed citations
20.
Jensen, Lars H., et al.. (1997). Agrobacterium tumefaciens-mediated transformation of Brassica napus winter cultivars. Transgenic Research. 6(4). 279–288. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Altschuler Breakdown of academic impact, for papers by Krzysztof Staroń Breakdown of academic impact, for papers by Marek Šarišský Breakdown of academic impact, for papers by Mithu Banerjee Breakdown of academic impact, for papers by Lulu Li Breakdown of academic impact, for papers by Prakash B. Palde Breakdown of academic impact, for papers by Rosalba Florio Breakdown of academic impact, for papers by Ikuo Mitsui Breakdown of academic impact, for papers by Sai-Peng Sim Breakdown of academic impact, for papers by Iwao Kitamura
Rankless by CCL
2026